Predictive Oncology Net Profit Margin 2010-2025 | POAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Predictive Oncology net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Predictive Oncology net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$47.5B
Hims & Hers Health (HIMS)	$12.9B
Doximity (DOCS)	$11.4B
Tempus AI (TEM)	$11.2B
IRhythm Technologies (IRTC)	$4.3B
Inspire Medical Systems (INSP)	$3.8B
Hinge Health (HNGE)	$3.6B
Privia Health (PRVA)	$2.4B
10x Genomics (TXG)	$1.7B
Schrodinger (SDGR)	$1.6B
Phreesia (PHR)	$1.6B
Azenta (AZTA)	$1.6B
Enovis (ENOV)	$1.6B
Clover Health Investments (CLOV)	$1.5B
Omnicell (OMCL)	$1.3B
Evolent Health (EVH)	$1.2B
Claritev (CTEV)	$652M
Fulgent Genetics (FLGT)	$559M
Standard BioTools (LAB)	$532M
Veradigm (MDRX)	$503M
Butterfly Network (BFLY)	$487M
Talkspace (TALK)	$421M
TruBridge (TBRG)	$353M
Outset Medical (OM)	$328M
Health Catalyst (HCAT)	$270M
Nyxoah SA (NYXH)	$258M
SOPHiA GENETICS SA (SOPH)	$240M
CapsoVision (CV)	$185M
Zepp Health (ZEPP)	$161M
KORU Medical Systems (KRMD)	$160M